AI Buyer Insights:

Westpac NZ, an Infosys Finacle customer evaluated nCino Bank OS

Citigroup, a VestmarkONE customer evaluated BlackRock Aladdin Wealth

Moog, an UKG AutoTime customer evaluated Workday Time and Attendance

Michelin, an e2open customer evaluated Oracle Transportation Management

Wayfair, a Korber HighJump WMS customer just evaluated Manhattan WMS

Swedbank, a Temenos T24 customer evaluated Oracle Flexcube

Cantor Fitzgerald, a Kyriba Treasury customer evaluated GTreasury

Westpac NZ, an Infosys Finacle customer evaluated nCino Bank OS

Citigroup, a VestmarkONE customer evaluated BlackRock Aladdin Wealth

Moog, an UKG AutoTime customer evaluated Workday Time and Attendance

Michelin, an e2open customer evaluated Oracle Transportation Management

Wayfair, a Korber HighJump WMS customer just evaluated Manhattan WMS

Swedbank, a Temenos T24 customer evaluated Oracle Flexcube

Cantor Fitzgerald, a Kyriba Treasury customer evaluated GTreasury

List of Epic Augmented Response Technology (ART) Customers

Apply Filters For Customers

Logo Customer Industry Empl. Revenue Country Vendor Application Category When SI Insight
Mayo Clinic Healthcare 80221 $17.9B United States Epic Systems Epic Augmented Response Technology (ART) Generative AI Platforms 2023 n/a
In 2023, Mayo Clinic piloted Epic Augmented Response Technology (ART) inside its Epic MyChart In-Basket as a Generative AI Platforms deployment for patient messaging and communication. The implementation used Epic Augmented Response Technology (ART) to generate draft MyChart replies intended for nursing staff, positioning the application as a compositional assistant embedded in the clinician messaging workflow. The implementation focused on the MyChart In-Basket ART capability, configuring automated draft generation for inbound patient messages while retaining clinician review controls. Functional configuration emphasized draft composition, templating assistance, and in-workflow editing, enabling nurses to accept or modify AI drafts prior to sending. This aligns with typical Generative AI Platforms workflows that automate content generation and preserve human oversight in patient communications. Architecturally the deployment was contained within Epic, integrating directly into the MyChart patient portal In-Basket messaging environment rather than as an external middleware component. Operational scope during the pilot covered nursing staff in the United States, with plans to expand access to licensed practical nurses and registered nurses by mid 2024. The relationship is clear, Mayo Clinic Epic Augmented Response Technology (ART) Generative AI Platforms patient messaging. Governance and rollout began as a controlled nursing pilot with clinician review required for all AI drafted replies, maintaining existing clinical communication signoff processes while introducing an AI-assisted drafting step. Initial pilot reporting documented roughly 30 seconds saved per message, and Mayo Clinic planned staged expansion to additional nursing roles by mid 2024 to broaden operational coverage. The deployment retained manual oversight and in-basket editing workflows to manage clinical accuracy and patient communication standards.
Mount Sinai Medical Center of Florida Healthcare 4000 $968M United States Epic Systems Epic Augmented Response Technology (ART) Generative AI Platforms 2023 n/a
In 2023 Mount Sinai Medical Center of Florida implemented Epic Augmented Response Technology (ART) within its Epic EHR environment, initially adopting English-language ART for MyChart and In-Basket patient messaging workflows. This deployment is classified under the Generative AI Platforms category and centers on AI drafted patient communication generated inside Epic MyChart and In-Basket interfaces. Epic Augmented Response Technology (ART) was configured to support message drafting for clinicians and patient communications, leveraging template and prompt controls typical of patient messaging implementations. Mount Sinai contributed requirements and content guidance to shape the behavior and phrasing of ART, and the implementation explicitly targeted MyChart message composition rather than broader clinical decision support modules. Following the English-language adoption, Mount Sinai worked with Epic to develop and validate a Spanish-language version of ART to draft MyChart messages for its large Spanish speaking patient population in Miami, the Spanish-language capability was developed with Mount Sinai input and rolled out in 2025. The integration is implemented inside Epic MyChart and In-Basket, preserving existing messaging workflows while adding AI drafting assistance to patient outreach and inbound message reply processes. Governance and operational controls were organized around clinician review of AI drafted content and MyChart messaging workflows, with Mount Sinai providing clinical and linguistic oversight during development. The narrative focuses on a patient messaging and communication implementation of Epic Augmented Response Technology (ART) within the Generative AI Platforms category, emphasizing configuration, system integration inside Epic, and institution led governance for language and content appropriateness.
Sutter Health Healthcare 53000 $13.2B United States Epic Systems Epic Augmented Response Technology (ART) Generative AI Platforms 2023 n/a
In 2023, Sutter Health implemented Epic Augmented Response Technology (ART), a Generative AI Platforms solution, to draft MyChart In-Basket patient message replies across primary care and specialty clinics in the United States. The rollout followed a pilot phase and expanded through staged specialty deployments, positioning ART inside clinician messaging workflows rather than as a standalone consumer tool. The implementation centered on Epic Augmented Response Technology (ART) embedded within MyChart In-Basket, delivering automated draft generation for patient communications, templated response suggestion, and contextual personalization tied to chart data. Functional configuration emphasized clinician-in-review workflows, allowing providers to edit and sign suggested replies, and applied category-aligned capabilities for natural language drafting and message triage. Integrations were explicitly MyChart In-Basket centric, with ART operating as an in-EHR messaging augmentation that leverages Epic messaging context and patient encounter metadata. Operational coverage targeted primary care and multiple specialty clinics across the United States, with adoption reported among clinicians handling inbound patient messages as part of routine ambulatory and specialty office workflows. Governance and rollout used a staged, pilot-to-scale approach, preserving clinician oversight and approval gates within message-handling processes. Sutter Health reported broad clinician adoption and measurable reductions in message-handling burden, citing over 217,000 ART-generated messages and reported time savings by the end of 2024.
Showing 1 to 3 of 3 entries

Buyer Intent: Companies Evaluating Epic Augmented Response Technology (ART)

ARTW Buyer Intent uncovers actionable customer signals, identifying software buyers actively evaluating Epic Augmented Response Technology (ART). Gain ongoing access to real-time prospects and uncover hidden opportunities.

Discover Software Buyers actively Evaluating Enterprise Applications

Logo Company Industry Employees Revenue Country Evaluated
No data found
FAQ - APPS RUN THE WORLD Epic Augmented Response Technology (ART) Coverage

Epic Augmented Response Technology (ART) is a Generative AI Platforms solution from Epic Systems.

Companies worldwide use Epic Augmented Response Technology (ART), from small firms to large enterprises across 21+ industries.

Organizations such as Mayo Clinic, Sutter Health and Mount Sinai Medical Center of Florida are recorded users of Epic Augmented Response Technology (ART) for Generative AI Platforms.

Companies using Epic Augmented Response Technology (ART) are most concentrated in Healthcare, with adoption spanning over 21 industries.

Companies using Epic Augmented Response Technology (ART) are most concentrated in United States, with adoption tracked across 195 countries worldwide. This global distribution highlights the popularity of Epic Augmented Response Technology (ART) across Americas, EMEA, and APAC.

Companies using Epic Augmented Response Technology (ART) range from small businesses with 0-100 employees - 0%, to mid-sized firms with 101-1,000 employees - 0%, large organizations with 1,001-10,000 employees - 33.33%, and global enterprises with 10,000+ employees - 66.67%.

Customers of Epic Augmented Response Technology (ART) include firms across all revenue levels — from $0-100M, to $101M-$1B, $1B-$10B, and $10B+ global corporations.

Contact APPS RUN THE WORLD to access the full verified Epic Augmented Response Technology (ART) customer database with detailed Firmographics such as industry, geography, revenue, and employee breakdowns as well as key decision makers in charge of Generative AI Platforms.